Showing results (231-240 of 276) with videos related to
Sort By:
Pageof 28
Brain Research|September 6, 1988
Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged ratsG Pezzoli, S Fahn, A Dwork, et al.Archives of Neurology|December 1, 1996
Use of intrathecal baclofen in the treatment of patients with dystoniaB Ford, P Greene, E D Louis, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 1993
Striatal 18F-dopa uptake: absence of an aging effectD Eidelberg, S Takikawa, V Dhawan, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's diseaseC W Olanow, S Fahn, M Muenter, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1992
Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicityS Przedborski, V Kostic, V Jackson-Lewis, et al.Muscle & Nerve|July 1, 1991
Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changesD J Lange, M Rubin, P E Greene, et al.Annals of Neurology|September 28, 1998
Functional brain networks in DYT1 dystoniaD Eidelberg, J R Moeller, A Antonini, et al.Nature Genetics|December 1, 1993
Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14qT G Nygaard, K C Wilhelmsen, N J Risch, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasmM F Brin, S Fahn, C Moskowitz, et al.Neurology|August 1, 1993
Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two womenC H Waters, H Takahashi, K C Wilhelmsen, et al.Pageof 28